Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-21-002022

Options or other derivatives

  • Chief Scientific Officer acquired 70,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Loose Christopher R. · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-01-15 Grant or award : show line 1 in the form Stock Option +70,000 $35.85 2031-01-14 70,000 70,000 D
Loading xslF345X03/form4.xml…